MedTrace Logo

Effect of a Cardiac Rehabilitation (CR) Programme on Molecular Mechanisms

NCT03907293 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2021-01-13

No results posted yet for this study

Summary

This study will evaluate the effect of a cardiac rehabilitation (CR) programme on blood protein molecules that may improve the function of arteries in coronary artery disease (CAD) patients who have suffered a heart attack. CAD patients who have either agreed or disagreed to take part in a CR programme will be recruited. This will allow a comparison of the study measurements between a group of patients who complete a CR programme and a group of patients who do not.

The other objective of this study is to perform interviews with the study participants and their significant others (i.e. spouse, family member, or a close friend) to listen to the reasons why patients agreed or disagreed to take part in a CR programme.

Conditions

Interventions

BEHAVIORAL

Exercise-based cardiac rehabilitation

Moderate intensity aerobic exercise, lifestyle advice, and psychological support.

Sponsors & Collaborators

  • Belfast Health and Social Care Trust

    collaborator OTHER

  • South Eastern Health and Social Care Trust

    collaborator OTHER

  • University of Ulster

    lead OTHER

Principal Investigators

  • Ciara Hughes, PhD · Ulster University

  • Gareth Thompson, PhD student · Ulster University

  • Gareth Davison, PhD · Ulster University

  • Jacqui Crawford, BSc, MSc · Ulster University

  • Lisa Spratt · Belfast Health and Social Care Trust

  • Maureen Morrison · South Eastern Health and Social Care Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-23
Primary Completion
2020-07-01
Completion
2020-07-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03907293 on ClinicalTrials.gov